-transparent.png){kind=logo}
The effect of a new non-steroid anti-inflammatory substance (bufexamac) in a special constituent was compared with that of 0.1% triamcinolone acetonide, 1% hydrocortisone cream, and placebo during a double-blind multicentre trial. The clinical effect of these four creams was studied in 193 patients receiving treatment for the following skin disorders: atopic dermatitis, allergic contact dermatitis, and non-allergic contact dermatitis, as well as dermatitis seborrheica. After 2 and 4 weeks' treatment, when 193 and 157 patients, respectively, were re-examined, the effect of triamcinolone acetonide and hydrocortisone cream was significantly better, than that obtained with bufexamac in the cream basis employed. On the other hand, no statistically significant difference in effect between bufexamac and placebo cream was observed.
J V Christiansen, and
E Gadborg, and
I Kleiter, and
K Ludvigsen, and
C H Meier, and
A Norholm, and
H Reiter, and
F Reymann, and
W Raaschou-Nielsen, and
M Sondergaard, and
P Unna, and
R Wehnert
January 1979,
Current medical research and opinion,
J V Christiansen, and
E Gadborg, and
I Kleiter, and
K Ludvigsen, and
C H Meier, and
A Norholm, and
H Reiter, and
F Reymann, and
W Raaschou-Nielsen, and
M Sondergaard, and
P Unna, and
R Wehnert
February 1970,
Current therapeutic research, clinical and experimental,
J V Christiansen, and
E Gadborg, and
I Kleiter, and
K Ludvigsen, and
C H Meier, and
A Norholm, and
H Reiter, and
F Reymann, and
W Raaschou-Nielsen, and
M Sondergaard, and
P Unna, and
R Wehnert
November 1988,
Archives of dermatology,
J V Christiansen, and
E Gadborg, and
I Kleiter, and
K Ludvigsen, and
C H Meier, and
A Norholm, and
H Reiter, and
F Reymann, and
W Raaschou-Nielsen, and
M Sondergaard, and
P Unna, and
R Wehnert
November 2010,
Mycoses,
J V Christiansen, and
E Gadborg, and
I Kleiter, and
K Ludvigsen, and
C H Meier, and
A Norholm, and
H Reiter, and
F Reymann, and
W Raaschou-Nielsen, and
M Sondergaard, and
P Unna, and
R Wehnert
June 2012,
Cutaneous and ocular toxicology,
J V Christiansen, and
E Gadborg, and
I Kleiter, and
K Ludvigsen, and
C H Meier, and
A Norholm, and
H Reiter, and
F Reymann, and
W Raaschou-Nielsen, and
M Sondergaard, and
P Unna, and
R Wehnert
January 1989,
International journal of clinical pharmacology research,
J V Christiansen, and
E Gadborg, and
I Kleiter, and
K Ludvigsen, and
C H Meier, and
A Norholm, and
H Reiter, and
F Reymann, and
W Raaschou-Nielsen, and
M Sondergaard, and
P Unna, and
R Wehnert
January 1995,
Dermatology (Basel, Switzerland),
J V Christiansen, and
E Gadborg, and
I Kleiter, and
K Ludvigsen, and
C H Meier, and
A Norholm, and
H Reiter, and
F Reymann, and
W Raaschou-Nielsen, and
M Sondergaard, and
P Unna, and
R Wehnert
September 2000,
International journal of STD & AIDS,
J V Christiansen, and
E Gadborg, and
I Kleiter, and
K Ludvigsen, and
C H Meier, and
A Norholm, and
H Reiter, and
F Reymann, and
W Raaschou-Nielsen, and
M Sondergaard, and
P Unna, and
R Wehnert
June 2024,
Pain,
J V Christiansen, and
E Gadborg, and
I Kleiter, and
K Ludvigsen, and
C H Meier, and
A Norholm, and
H Reiter, and
F Reymann, and
W Raaschou-Nielsen, and
M Sondergaard, and
P Unna, and
R Wehnert
January 1994,
Mycoses,
